REARDON ANDREW (CLO & Secretary) sold 1.5% of their position (500.00 shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $57.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/12/2025ACC: 0002001011-25-000047
Officer· CLO & Secretary
Since Mar 2026
-500.00
Net shares
Net seller
$57.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
500.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−500.00
Price / share
$114.54
Trade value
$57.27K
% of position
1.5%
6/10/2025
32.90K→32.40K
Total
Net shares
−500.00
Net value
-$57.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2025 | S · Sale | −500.00 | $114.54 | $57.27K | 1.5% | 32.90K | 32.40K |
| Total | −500.00 | -$57.27K | ||||||
Derivative Transactions0
No derivative transactions reported